Shajitha Parveen H*

Department of Ophthalmology, Appasamy Eye Hospital, Chennai, India

*Corresponding Author: Shajitha Parveen H, Department of Ophthalmology, Appasamy Eye Hospital, Chennai, India.

Received: August 07, 2022; Published: October 01, 2022

Glaucoma is a leading cause of irreversible blindness worldwide. It has been estimated that 76 million people would have developed glaucoma in 2020 and the number is likely to reach 111.8 million by 2040 [1]. Asia accounts for more than half of the world’s overall glaucoma burden and more than three-quarters of the global Primary Angle Closure Glaucoma (PACG) population [1,2]. A recent systemic review and meta-analysis of population-based studies reported that 64.7% of PACG cases were previously undetected in Asia [3]. Although Primary Open Angle Glaucoma (POAG) is the most common subtype of glaucoma, the increased propensity of PACG to cause permanent blindness makes it a pressing public health issue, especially in Asia [4,5]. It is reported that angle closure glaucoma is associated with a three-fold increased risk of bilateral visual impairment [6].

References

1. Tham Yih-Chung, et al. "Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis”. Ophthalmology11 (2014): 2081-2090.
2. Wong T Y., et al. "The epidemiology of age related eye diseases in Asia”. British Journal of Ophthalmology4 (2006): 506-511.
3. Soh Zhi., et al. "The global extent of undetected glaucoma in adults: a systematic review and meta-analysis”. Ophthalmology10 (2021): 1393-1404.
4. Foster Paul J. "The epidemiology of primary angle closure and associated glaucomatous optic neuropathy”. Seminars in Ophthalmology2 (2002).
5. Chan Errol Wei'en., et al. "Glaucoma in Asia: regional prevalence variations and future projections”. British Journal of Ophthalmology1 (2016): 78-85.
6. Friedman David S., et al. "Angle closure and angle‐closure glaucoma: what we are doing now and what we will be doing in the future”. Clinical and Experimental Ophthalmology4 (2012): 381-387.
7. Foster Paul J., et al. "The definition and classification of glaucoma in prevalence surveys”. British Journal of Ophthalmology2 (2002): 238-242.
8. Weinreb Robert N and David S. Friedman, eds. Angle closure and angle closure Glaucoma: reports and consensus statements of the 3rd global AIGS consensus meeting on angle closure Glaucoma. Kugler Publications, 3 (2006).
9. Weinreb Robert N. “Glaucoma screening”. Kugler Publications, 5 (2008).
10. Thomas Ravi., et al. "The flashlight test and van Herick's test are poor predictors for occludable angles”. Australian and New Zealand Journal of Ophthalmology3 (1996): 251-256.
11. Salmon John F., et al. "The prevalence of primary angle closure glaucoma and open angle glaucoma in Mamre, western Cape, South Africa”. Archives of Ophthalmology9 (1993): 1263-1269.
12. Foster Paul J., et al. "Glaucoma in Mongolia: a population-based survey in Hövsgöl Province, northern Mongolia”. Archives of Ophthalmology10 (1996): 1235-1241.
13. Jacob Aby., et al. "Prevalence of primary glaucoma in an urban south Indian population”. Indian Journal of Ophthalmology2 (1998): 81.

Citation

Citation: Shajitha Parveen H. “A Step Towards Reducing Global Glaucoma Blindness - How does Gonioscopy Help?".Acta Scientific Ophthalmology 5.11 (2022): 01-02.

Copyright

Copyright: © 2022 Shajitha Parveen H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.